IMARC Group has published a market research report titled "United States Dry Eye Syndrome Market Report by Disease Type (Evaporative Dry Eye Syndrome, Aqueous Dry Eye Syndrome), Drug Type (Anti-inflammatory Drugs, Lubricant Eye Drops, Autologous Serum Eye Drops), Product (Liquid Drops, Gel, Liquid Wipes, Eye Ointment, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032", The United States dry eye syndrome market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.4% during 2024-2032.

The rising utilization of digital devices and the growing prevalence of the condition among the aging population are the primary factors responsible for the growth of the United States dry eye syndrome market. Additionally, as the population ages, the incidence of dry eye-related symptoms escalates, which is creating an issue with the ailment of dry eye syndrome. Moreover, the modern lifestyle, which often includes prolonged exposure to computer screens and smartphones, exacerbates the symptoms of dry eye syndrome. This condition is now becoming more recognized and diagnosed, leading to a higher demand for effective treatment solutions, which is further bolstering the market. Moreover, rising public awareness of eye health issues, as well as the availability of numerous over-the-counter and prescription therapies, help to drive market growth.

Grab a sample PDF of this report: https://www.imarcgroup.com/united-states-dry-eye-syndrome-market/requestsample

United States Dry Eye Syndrome Market Trends and Drivers:

Advancements in medical research and pharmaceutical innovations are significant drivers of the United States dry eye syndrome market. In addition to this, new treatments, including advanced lubricant eye drops, anti-inflammatory drugs, and tear-stimulating drugs, are being developed and have gained approval from regulatory bodies such as the FDA, acting as another growth-inducing factor. These developments not only provide more effective relief for patients but also widen the range of treatment options available, catering to different severity levels of the condition. Furthermore, the role of specialty eye care clinics and optometrists has expanded, providing more specialized and accessible care for dry eye sufferers, which is anticipated to drive the United States dry eye syndrome market over the forecasted period.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Disease Type:

• Evaporative Dry Eye Syndrome
• Aqueous Dry Eye Syndrome

Breakup by Drug Type:

• Anti-inflammatory Drugs
• Lubricant Eye Drops
• Autologous Serum Eye Drops

Breakup by Product:

• Liquid Drops
• Gel
• Liquid Wipes
• Eye Ointment
• Others

Breakup by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Breakup by Region:

• Northeast
• Midwest
• South
• West

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163